These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30058959)

  • 21. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012389. PubMed ID: 28500860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silent brain infarcts and the risk of dementia and cognitive decline.
    Vermeer SE; Prins ND; den Heijer T; Hofman A; Koudstaal PJ; Breteler MM
    N Engl J Med; 2003 Mar; 348(13):1215-22. PubMed ID: 12660385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ASPREE-NEURO study protocol: A randomized controlled trial to determine the effect of low-dose aspirin on cerebral microbleeds, white matter hyperintensities, cognition, and stroke in the healthy elderly.
    Ward SA; Raniga P; Ferris NJ; Woods RL; Storey E; Bailey MJ; Brodtmann A; Yates PA; Donnan GA; Trevaks RE; Wolfe R; Egan GF; McNeil JJ;
    Int J Stroke; 2017 Jan; 12(1):108-113. PubMed ID: 27634976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis.
    O'Sullivan M; Morris RG; Huckstep B; Jones DK; Williams SC; Markus HS
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):441-7. PubMed ID: 14966162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study.
    Lamy A; Eikelboom J; Sheth T; Connolly S; Bosch J; Fox KAA; Zhu J; Lonn E; Dagenais G; Widimsky P; Branch KRH; Bhatt DL; Zheng Z; Straka Z; Dagenais F; Kong Y; Marsden T; Lee SF; Copland I; Yusuf S
    J Am Coll Cardiol; 2019 Jan; 73(2):121-130. PubMed ID: 30654882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lacunar infarcts are the main correlate with cognitive dysfunction in CADASIL.
    Liem MK; van der Grond J; Haan J; van den Boom R; Ferrari MD; Knaap YM; Breuning MH; van Buchem MA; Middelkoop HA; Lesnik Oberstein SA
    Stroke; 2007 Mar; 38(3):923-8. PubMed ID: 17272761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial.
    Vanassche T; Verhamme P; Anand SS; Shestakovska O; Fox KA; Bhatt DL; Avezum A; Alings M; Aboyans V; Maggioni AP; Widimsky P; Berkowitz SD; Yusuf S; Connolly SJ; Eikelboom JW; Bosch J
    Eur J Prev Cardiol; 2020 Feb; 27(3):296-307. PubMed ID: 31615291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and Rationale for a Cognitive Outcome Substudy in Ischemic Stroke Patients with High Risk of Cerebral Hemorrhage.
    Yu KH; Hong KS; Oh MS; Lee J; Lee JS; Kwon SU;
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):2061-6. PubMed ID: 27263034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced Cognitive Assessment Scores Among Individuals With Magnetic Resonance Imaging-Detected Vascular Brain Injury.
    Anand SS; Friedrich MG; Desai D; Schulze KM; Awadalla P; Busseuil D; Dummer TJB; Jacquemont S; Dick A; Kelton D; Kirpalani A; Lear SA; Leipsic J; Noseworthy MD; Parker L; Parraga G; Poirier P; Robson P; Tardif JC; Teo K; Vena J; Yusuf S; Moody AR; Black SE; Smith EE;
    Stroke; 2020 Apr; 51(4):1158-1165. PubMed ID: 32126938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rivaroxaban vs Warfarin Sodium in the Ultra-Early Period After Atrial Fibrillation-Related Mild Ischemic Stroke: A Randomized Clinical Trial.
    Hong KS; Kwon SU; Lee SH; Lee JS; Kim YJ; Song TJ; Kim YD; Park MS; Kim EG; Cha JK; Sung SM; Yoon BW; Bang OY; Seo WK; Hwang YH; Ahn SH; Kang DW; Kang HG; Yu KH;
    JAMA Neurol; 2017 Oct; 74(10):1206-1215. PubMed ID: 28892526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rivaroxaban versus Clopidogrel for Peripheral Artery Disease: A Clinico-Economic Approach of the COMPASS Trial.
    Tsilimigras DI; Moris D; Karaolanis G; Kakkos SK; Filis K; Sigala F
    Curr Pharm Des; 2018; 24(38):4516-4517. PubMed ID: 30621559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of Covert Lacunar Infarcts and White Matter Hyperintensities on Cognitive and Motor Outcomes After Stroke.
    Auriat AM; Ferris JK; Peters S; Ramirez J; Black SE; Jacova C; Boyd LA
    J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):381-388. PubMed ID: 30409743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods.
    Charidimou A; Wilson D; Shakeshaft C; Ambler G; White M; Cohen H; Yousry T; Al-Shahi Salman R; Lip G; Houlden H; Jäger HR; Brown MM; Werring DJ
    Int J Stroke; 2015 Oct; 10 Suppl A100():155-61. PubMed ID: 26235450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral microbleeds are common in ischemic stroke but rare in TIA.
    Werring DJ; Coward LJ; Losseff NA; Jäger HR; Brown MM
    Neurology; 2005 Dec; 65(12):1914-8. PubMed ID: 16380612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral microbleeds on T2*-weighted images and hemorrhagic transformation after antithrombotic therapies for ischemic stroke.
    Takahashi W; Moriya Y; Mizuma A; Uesugi T; Ohnuki Y; Takizawa S
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e528-32. PubMed ID: 23830955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging agents for the treatment and prevention of stroke: progress in clinical trials.
    Safouris A; Magoufis G; Tsivgoulis G
    Expert Opin Investig Drugs; 2021 Oct; 30(10):1025-1035. PubMed ID: 34555978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and radiological determinants of prestroke cognitive decline in a stroke cohort.
    Pohjasvaara T; Mäntylä R; Aronen HJ; Leskelä M; Salonen O; Kaste M; Erkinjuntti T
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):742-8. PubMed ID: 10567490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events: A Secondary Analysis of the COMPASS Trial.
    Gaba P; Bhatt DL; Dagenais GR; Bosch J; Maggioni AP; Widimsky P; Leong D; Fox KAA; Yusuf S; Eikelboom JW;
    JAMA Netw Open; 2022 Nov; 5(11):e2243201. PubMed ID: 36409491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.